Pharmaceuticals, Biotechnology and Life Sciences
DUBLIN–(BUSINESS WIRE)–The “Zocor – Drug Insight, 2019” report has been added to ResearchAndMarkets.com’s offering. Zocor – Drug Insight, 2019 highlights…
DUBLIN–(BUSINESS WIRE)–The “Lyrica – Drug Insight, 2019” report has been added to ResearchAndMarkets.com’s offering. Lyrica – Drug Insight, 2019 highlights…
DUBLIN–(BUSINESS WIRE)–The “Uniflox – Drug Insight, 2019” report has been added to ResearchAndMarkets.com’s offering. Uniflox – Drug Insight, 2019 highlights…
DUBLIN–(BUSINESS WIRE)–The “Copaxone – Drug Insight, 2019” report has been added to ResearchAndMarkets.com’s offering. Copaxone Drug Insight, 2019 highlights the…
DUBLIN–(BUSINESS WIRE)–The “Tekturna – Drug Insight, 2019” report has been added to ResearchAndMarkets.com’s offering. Tekturna – Drug Insight, 2019 highlights…
DUBLIN–(BUSINESS WIRE)–The “Eviplera – Drug Insight, 2019” report has been added to ResearchAndMarkets.com’s offering. Eviplera – Drug Insight, 2019 highlights…
REDWOOD CITY, Calif.–(BUSINESS WIRE)–Soleno Therapeutics, Inc. (NASDAQ: SLNO), a clinical-stage
biopharmaceutical company developing novel therapeutics for the
treatment of rare diseases, today announced that the Data Safety
Moni…
– “When-issued” trading of CYCN expected to begin on Nasdaq on March
18, 2019 –
– Separation completion expected April 1, 2019 –
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Ironwood
Pharmaceuticals, Inc. (Nasdaq: IRWD…
LOS ANGELES–(BUSINESS WIRE)–Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company,
announced that on March 12, 2019 the Compensation Committee of Puma’s
Board of Directors approved the grant of inducement restricted stock…
CHICAGO–(BUSINESS WIRE)–Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical
company leveraging its novel technology platforms to develop and
commercialize ready-to-use injectable and infusible drug formulations,
…